Stop wasting hours on dense SEC filings. Get AI-powered summaries of any SEC Filings in seconds. Understand key insights and risks, fast.
Currently we only process Form 8-K, 6-K, 3, 4, 144, Schedule 13D and Schedule 13G. We will support more forms in the future.
Filter by Form Type:
Industry:Biotechnologyβ
2026-04-16NVAX3Robert E. Walker Form 3 Filing and Power of Attorney for Novavax, Inc.
This SEC Form 3 filing reports the initial beneficial ownership of securities by Robert E. Walker, Executive Vice President of R&D at Novavax, Inc. The filing discloses Walker's holdings as of April 14, 2026, including 34,386 shares of common stock and multiple equity awards. The filing includes six derivative holdings...
Small CapBiotechnology
2026-04-15ATHE3Form 3 Filing for David Allen Stamler - Alterity Therapeutics LtdMEDIUM
This filing reports on Form 3, Initial Statement of Beneficial Ownership, for David Allen Stamler, Chief Executive Officer and Director of Alterity Therapeutics Ltd. The report details direct ownership of 11,688,312 ordinary shares. Additionally, it lists holdings of various options, including: a listed option expiring...
Micro CapBiotechnology